Open AccessHow often is patent foramen ovale an innocent bystander?
Author(s) -
Versaci Francesco,
Vizzari Giampiero,
Sergi Domenico,
Andò Giuseppe,
Trivisonno Antonio,
Romeo Francesco
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1237
Subject(s) - medicine , patent foramen ovale , presyncope , paradoxical embolism , cardiology , flecainide , stroke (engine) , atrial fibrillation , migraine , mechanical engineering , heart rate , blood pressure , engineering
Key Clinical Message Patent foramen ovale (PFO) is a risk factor for cryptogenetic stroke; its closure should be considered in selected patients. It is not always clear whether symptoms (presyncope, paresthesia) apparently due to paradoxical embolism are related with other cardiovascular disorders such as arrhythmias. Flecainide administration for post‐ PFO ‐closure supraventricular arrhythmias can unmask a latent undiagnosed Brugada syndrome.